Diet has been described as a modifiable risk factor for the development and progression of
chronic diseases, and emerging evidence increasingly points to its preventive and …

Early career members of Assembly 3 (Basic and Translational Sciences) of the European
Respiratory Society (ERS) summarise the key messages discussed during six selected …

Sarcopenia, defined as the loss of muscle mass and strength, is a major cause of morbidity
and mortality in COPD (chronic obstructive pulmonary disease) patients. However, the …

Background Chronic diseases such as chronic obstructive pulmonary disease (COPD) have
been linked to low levels of physical activity (PA) and higher frequency of leisure sedentary …

Background: Chronic obstructive pulmonary disease has extrapulmonary manifestations,
such as cardiovascular diseases and osteoporosis. The purpose of this research was to …

Aim Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
obstruction and development of emphysema. Among the comorbidities associated with …

Muscle atrophy is a common extrapulmonary co-morbidity affecting about 20% of patients
with COPD. However, the mechanism of muscle atrophy in COPD remains unclear. This …

Purpose To explore the predictive value of skeletal muscle function measurement combined
with stair climbing test for postoperative cardiopulmonary complications in patients with …

Background: Patients with chronic obstructive pulmonary disease (COPD) with low skeletal
muscle mass and severe airway obstruction have higher mortality risks. However, the …

Introducción: La enfermedad pulmonar obstructiva crónica produce disnea y tos, y causa 3
millones de defunciones al año. El objetivo fue analizar la evidencia sobre los efectos del …